Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Shandong Xinhua Pharmaceutical Co Ltd?

Accepted Answer

Según el último estado financiero (Form-10K), Shandong Xinhua Pharmaceutical Co Ltd tiene un total de activos de $9,019, una ganancia neta profit de $470

Question 2

¿Cuáles son los ratios financieros clave para SHNXY?

Accepted Answer

El ratio corriente de Shandong Xinhua Pharmaceutical Co Ltd es 2.23, el margen neto es 5.55, las ventas por acción son $12.24.

Question 3

¿Cómo se desglosan los ingresos de Shandong Xinhua Pharmaceutical Co Ltd por segmento o geografía?

Accepted Answer

Shandong Xinhua Pharmaceutical Co Ltd largest revenue segment is Preparation, at a revenue of 4,072,208,527 in the most earnings release.For geography, China (including Hong Kong) is the primary market for Shandong Xinhua Pharmaceutical Co Ltd, at a revenue of 6,332,209,258.

Question 4

¿Es rentable Shandong Xinhua Pharmaceutical Co Ltd?

Accepted Answer

yes, según los últimos estados financieros, Shandong Xinhua Pharmaceutical Co Ltd tiene una ganancia neta profit de $470

Question 5

¿Tiene Shandong Xinhua Pharmaceutical Co Ltd alguna deuda?

Accepted Answer

yes, Shandong Xinhua Pharmaceutical Co Ltd tiene una deuda de 4,028

Question 6

¿Cuántas acciones en circulación tiene Shandong Xinhua Pharmaceutical Co Ltd?

Accepted Answer

Shandong Xinhua Pharmaceutical Co Ltd tiene un total de acciones en circulación de 682.4

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	8,494	8,466	8,100	7,502	6,560	6,005
Revenue Growth (YoY)	2%	5%	8%	14%	9%	7%
Cost of Revenue	6,805	6,476	5,772	5,509	4,819	4,238
Gross Profit	1,689	1,989	2,328	1,993	1,740	1,767
Selling, General & Admin	832	973	1,300	1,085	912	949
Research & Development	386	393	419	345	341	298
Operating Expenses	1,227	1,452	1,787	1,497	1,271	1,269
Other Non Operating Income (Expenses)	-1	4	2	-2	-2	-6
Pretax Income	446	533	532	471	421	411
Income Tax Expense	48	46	26	45	59	64
Net Income	382	470	496	411	348	324
Net Income Growth	-15%	-5%	21%	18%	7%	8%
Shares Outstanding (Diluted)	678.98	691.21	689.6	660.6	627.1	621.9
Shares Change (YoY)	-3%	0%	4%	5%	1%	0%
EPS (Diluted)	0.54	0.68	0.72	0.62	0.56	0.52
EPS Growth	-15%	-6%	16%	11%	8%	8%
Free Cash Flow	268	155	-59	513	9	140
Free Cash Flow Per Share	0.39	0.22	-0.08	0.77	0.01	0.22
Gross Margin	19.88%	23.49%	28.74%	26.56%	26.52%	29.42%
Operating Margin	5.42%	6.34%	6.66%	6.61%	7.14%	8.29%
Profit Margin	4.49%	5.55%	6.12%	5.47%	5.3%	5.39%
Free Cash Flow Margin	3.15%	1.83%	-0.72%	6.83%	0.13%	2.33%
EBITDA	--	677	631	588	541	552
EBITDA Margin	--	7.99%	7.79%	7.83%	8.24%	9.19%
D&A For EBITDA	--	140	91	92	72	54
EBIT	461	537	540	496	469	498
EBIT Margin	5.42%	6.34%	6.66%	6.61%	7.14%	8.29%
Effective Tax Rate	10.76%	8.63%	4.88%	9.55%	14.01%	15.57%

Shandong Xinhua Pharmaceutical Co Ltd (SHNXY) Price

SHNXY Stock Price Chart

SHNXY Income

Follow-Up Questions